Skip to content
Vensana Capital

Vensana Capital

Transforming Healthcare Through Medtech Innovation

  • Our Team
  • Values
  • Our Entrepreneurs

Category: Uncategorized

Uncategorized

Vensana Capital Launches Vensana Innovation and Adds Thomas Tu, MD, as Venture Partner

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

32

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
SpyGlass Pharma Announces Pricing of Initial Public Offering
Ventaris Surgical, Inc. Announces $30M Series A to Advance a Next-Generation System for Complete Kidney Stone Treatment
Apella Raises $80 Million to Transform the Hospital with Ambient AI and Computer Vision
Resources
News Vensana Innovation LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 7900 Tysons One Place Suite 320 McLean, VA 22102

© 2026 Vensana Capital Management, LLC | Privacy | Terms & Conditions